Geleen, Netherlands · Founded 2018 · Privately Held (backing)
Developer of metabolite-based biofungicides designed to control plant diseases through non-living microbial compounds. BioMosae is based in Geleen, Netherlands and was founded in 2018. Its last reported valuation was $2.5 million in Sep 2022. It has raised $3.7 million.
Last reported valuation
$2.5M
Oct 2026
Priced at
—
Total raised
$3.7M
Last round
—
Cap table — not yet on record
BioMosae's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BioMosae with a free account
·Watch BioMosae: the Monday email on marks, rounds and moves
